Literature DB >> 28890548

Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases.

Heng Li1,2, Jianping Zuo1,2, Wei Tang1,2.   

Abstract

Entities:  

Year:  2017        PMID： 28890548      PMCID： PMC5675962          DOI： 10.1038/cmi.2017.87

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  17 in total

Review 1.  Cellular and molecular regulation of innate inflammatory responses.

Authors:  Juan Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2016-10-31       Impact factor: 11.530

Review 2.  Pathogenesis of membranous nephropathy: recent advances and future challenges.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Nat Rev Nephrol       Date:  2012-02-28       Impact factor: 28.314

3.  Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.

Authors:  Li-Fei Hou; Shi-Jun He; Xin Li; Yang Yang; Pei-Lan He; Yu Zhou; Feng-Hua Zhu; Yi-Fu Yang; Ying Li; Wei Tang; Jian-Ping Zuo
Journal:  Arthritis Rheum       Date:  2011-08

4.  Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.

Authors:  Yanwei Wu; Shijun He; Bingxin Bai; Luyao Zhang; Lu Xue; Zemin Lin; Xiaoqian Yang; Fenghua Zhu; Peilan He; Wei Tang; Jianping Zuo
Journal:  Cell Mol Immunol       Date:  2015-03-16       Impact factor: 11.530

5.  SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo.

Authors:  Li-Fei Hou; Shi-Jun He; Jun-Xia Wang; Yang Yang; Feng-Hua Zhu; Yu Zhou; Pei-Lan He; Yu Zhang; Yi-Fu Yang; Ying Li; Wei Tang; Jian-Ping Zuo
Journal:  Int Immunopharmacol       Date:  2009-09-19       Impact factor: 4.932

6.  SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-kappaB pathways in RAW 264.7 macrophages.

Authors:  Jun-Xia Wang; Li-Fei Hou; Yang Yang; Wei Tang; Ying Li; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2009-10       Impact factor: 6.150

7.  The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses.

Authors:  J-X Wang; W Tang; R Zhou; J Wan; L-P Shi; Y Zhang; Y-F Yang; Y Li; J-P Zuo
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

8.  Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo.

Authors:  Jun-Xia Wang; Wei Tang; Zhong-Shun Yang; Jin Wan; Li-Ping Shi; Yu Zhang; Ru Zhou; Jia Ni; Li-Fei Hou; Yu Zhou; Pei-Lan He; Yi-Fu Yang; Ying Li; Jian-Ping Zuo
Journal:  Eur J Pharmacol       Date:  2007-02-16       Impact factor: 4.432

9.  Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell.

Authors:  Xin Li; Tian-Tian Li; Xiao-Hui Zhang; Li-Fei Hou; Xiao-Qian Yang; Feng-Hua Zhu; Wei Tang; Jian-Ping Zuo
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

Review 10.  The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Samuel S Duffy; Justin G Lees; Gila Moalem-Taylor
Journal:  Mult Scler Int       Date:  2014-10-12
View more
  5 in total

1.  Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages.

Authors:  Yu-Xi Yan; Mei-Juan Shao; Qing Qi; Yan-Sheng Xu; Xiao-Qian Yang; Feng-Hua Zhu; Shi-Jun He; Pei-Lan He; Chun-Lan Feng; Yan-Wei Wu; Heng Li; Wei Tang; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2018-05-31       Impact factor: 6.150

Review 2.  Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives.

Authors:  Boshi Huang; Yan Zhang
Journal:  Drug Discov Today       Date:  2022-02-16       Impact factor: 8.369

3.  Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial.

Authors:  Qi Chen; Zi Wang; Jicheng Lv; Lijun Liu; Hang Li; Weiwei Sun; Yanhong Huo; Yingbo Guo; Cun Shen; Shichao Li; Zhenjie Chen; Jingwei Zhou
Journal:  Trials       Date:  2022-05-25       Impact factor: 2.728

Review 4.  Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus.

Authors:  Rui-Jie Ma; Ming-Jing He; Ya-Qin Tan; Gang Zhou
Journal:  Inflamm Res       Date:  2019-02-01       Impact factor: 4.575

5.  [Artesunate attenuate chronic graft-versus-host disease by regulating Th17/Treg balance].

Authors:  X M Chen; J Y Weng; P L Lai; Y L Wang; X Huang; S X Geng; L Y Guo; T Huang; L J Zeng; X Du
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.